Medical glass sheet cleaning and sterilizing treatment method

By combining modified graphene and silver ion antibacterial agent, acrylamide hydrogel is formed to cover the glass sheet, solving the cleaning and wear problems of traditional medical glass products, achieving long-term antibacterial and biocompatibility, and expanding its Applications in the medical field.

CN118987300AInactive Publication Date: 2024-11-22TAI DEJI MEDICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411089474.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-09
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Traditional medical glass products need to be repeatedly cleaned and disinfected during storage and use, which are prone to wear and produce fine glass fragments and impurities. Some glass materials have osteoinductive effects, but their application is limited.

Method used

Use polytetrafluoroethylene to disperse graphene oxide and modify hydrofluoric acid, prepare silver ion antibacterial agent and mix it with modified graphene to form an acrylamide hydrogel, cover it on a glass sheet, combine dopamine hydrochloride modification and oxidant trigger Cross-linking to form a long-acting antibacterial protective film.

Benefits of technology

It realizes the long-term antibacterial effect of glass sheets, reduces wear and debris generation, enhances biocompatibility and stability, is suitable for medical equipment and cell culture, and provides a wider application potential.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004986112050000101
    Figure BDA0004986112050000101
Patent Text Reader

Abstract

The invention relates to a medical glass sheet cleaning and sterilizing treatment method, and belongs to the technical field of glass surface treatment.The medical glass sheet cleaning and sterilizing treatment method comprises the following steps that graphene oxide is dispersed through polytetrafluoroethylene and then modified through hydrofluoric acid, and the obtained modified graphene and a silver ion antibacterial agent are mixed to be used for preparing acrylamide hydrogel; the preparation method comprises the following steps: modifying acrylic acid by using dopamine hydrochloride, coating the surface of a clean and sterile glass sheet with the modified acrylic acid, dropwise adding a proper amount of an oxidizing agent, and then coating a layer of acrylamide hydrogel to obtain the medical glass sheet. The glass sheet wrapped by the gel has a long-acting antibacterial effect, meanwhile, the durability of the glass sheet is increased, the number of glass fragments is reduced during storage collision, the loss of the glass sheet is reduced, and meanwhile, the cleaned glass sheet has a good cell proliferation promoting effect and biocompatibility, so that the service life of the glass sheet is prolonged, and the service life of the glass sheet is prolonged. The compound has a better application prospect and a wider application range in the field of medicines.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of glass surface treatment, and in particular, relates to a method for cleaning and sterilizing medical glass sheets. Background Art

[0002] Glass is highly chemically resistant and therefore does not react with cleaners, detergents, acids, bases, solvents or adhesives, which makes glass components long-lasting and easy to clean. Glass is also inert, meaning there is no risk of allergic reactions because it does not provoke any immune response in the body. In contrast, plastics can react with a wide range of chemicals and sometimes provoke an immune response in the human body. Many plastics cannot be used in low-temperature treatment processes for medical devices, such as plasma sterilization, because they react with the hydrogen peroxide used in such processes. The many excellent properties of glass materials make them well suited for use in the medical field.

[0003] However, glass used in medical applications often needs to be cleaned and disinfected repeatedly due to storage and use, and is often worn. If used as a container, it will also produce fine glass slag, which mixes with the solution to form impurities. In addition, glass products have good biocompatibility, and some glass also has bone induction effects, which can be used more widely in the medical field. Summary of the invention

[0004] The object of the present invention is to provide a method for cleaning and sterilizing medical glass sheets, wherein polytetrafluoroethylene is used to disperse graphene oxide, and then hydrofluoric acid is used to modify it, and the obtained modified graphene is mixed with a silver ion antibacterial agent to prepare acrylamide hydrogel; dopamine hydrochloride is used to modify acrylic acid, and the acrylic acid is coated on the surface of a clean and sterile glass sheet, and after an appropriate amount of oxidant is added, a layer of acrylamide hydrogel is coated to obtain a medical glass sheet. The gel-wrapped glass sheet has a long-lasting antibacterial effect, and at the same time increases the durability of the glass sheet, and also reduces the amount of glass slag during storage collision, thereby reducing the loss of the glass sheet.

[0005] The technical problems to be solved by the present invention are:

[0006] The present invention solves the problem that the glass used in traditional medical treatment often needs to be repeatedly cleaned and disinfected due to storage and use, and often wears out. If it is used as a container, it will also produce fine glass slag, which mixes in the solution to form impurities. In addition, the glass products have good biocompatibility, and some glasses also have bone induction effects, which can be more widely used in the medical field.

[0007] The purpose of the present invention can be achieved by the following technical solutions:

[0008] A method for cleaning and sterilizing medical glass sheets comprises the following steps:

[0009] (1) After washing the glass slide with sterile deionized water for 3 times, soaking it in a 75% ethanol solution, wiping the surface of the glass slide with a cotton ball, rinsing it with a 75% ethanol solution, and finally drying it in an ultraviolet sterilization dryer to obtain a pretreated glass slide;

[0010] (2) using polytetrafluoroethylene to disperse graphene oxide, and then using hydrofluoric acid to modify it to obtain modified graphene, and storing it for standby use, the specific steps are as follows:

[0011] A1. Disperse graphene oxide powder in sterile deionized ultrapure water, stir evenly, add polytetrafluoroethylene and perform ultrasonic treatment for 30 minutes to obtain a graphene oxide solution;

[0012] A2. Transfer the graphene oxide solution to a Teflon-lined autoclave, add hydrofluoric acid, stir, filter, and then place the system in an oven and dry at 180°C for 12 hours. Then, cool the mixture naturally to room temperature, filter, discard the supernatant, wash the filter cake with sterile deionized water until the pH value of the washing solution is 7, and then dry again to obtain modified graphene.

[0013] In the above reaction process, graphene oxide is prepared in the first step, oxygen-containing functional groups such as hydroxyl, carboxyl and epoxy groups are introduced on the edges and planes of graphene, and then the graphene oxide is fluorinated by a liquid phase method, so that fluorine atoms replace the oxygen-containing groups in the graphene oxide to obtain modified graphene.

[0014] (3) preparing a silver ion antibacterial agent, adding modified graphene to the silver ion antibacterial agent to obtain a composite antibacterial solution, the specific steps are:

[0015] A 30% concentration of pentasodium diethylenetriamine pentaacetate solution is added to sterile deionized water, and the mixture is stirred evenly before adding silver oxide powder. The mixture is stirred at 30 rpm at room temperature for 1 hour, and lauric acid is added and continued to be stirred until the lauric acid is completely dissolved. The mixture is filtered using a 0.22 μm filter to obtain a silver ion antibacterial agent. The silver ion antibacterial agent is mixed with modified graphene, and stirred at 30 rpm at room temperature until uniform to obtain a composite antibacterial solution.

[0016] In the above reaction process, pentasodium diethylenetriamine pentaacetate solution is used as a chelating agent and lauric acid is used as a buffer. While maintaining the antibacterial effect of silver ions, the silver ions are converted into a chelated state. The chelate formed by the metal ions has excellent stability, which increases the stability of the silver ions. Compared with silver ions, chelated silver ions have lower toxicity to certain algae and other organisms, reducing the impact of silver ions on the environment.

[0017] (4) using the composite antibacterial solution to prepare acrylamide hydrogel to obtain acrylamide hydrogel, the specific steps are:

[0018] B1. Under light-proof conditions, add 13.52 g of acrylamide powder to 100 mL of the composite antibacterial solution, and stir at room temperature until dissolved to obtain an acrylamide solution; add 2 g of N,N′-methylenebisacrylamide to 100 mL of sterile deionized ultrapure water and stir evenly to obtain an N,N′-methylenebisacrylamide solution; mix the N,N′-methylenebisacrylamide solution with the acrylamide solution to obtain a precursor solution;

[0019] B2, adding 20g of ammonium persulfate to 100mL of sterile deionized ultrapure water and stirring evenly to obtain an ammonium persulfate solution, then adding N,N,N',N'-tetramethylethylenediamine to the ammonium persulfate solution, stirring evenly to obtain a crosslinking accelerator;

[0020] B3. After the cross-linking accelerator and the precursor solution are evenly mixed, a mixed solution is obtained and set aside; a layer of silicone gasket is added to the reaction container, and then the mixed solution is transferred to the reaction container, and treated in an oven at 50° C. for 5 hours to obtain acrylamide hydrogel.

[0021] (5) In a sterile environment, a polyacrylic acid solution is prepared using sterile deionized water, and modified using dopamine hydrochloride to obtain an adhesion initiator. The specific steps are as follows:

[0022] C1, add 0.585g 0.1mol / L 2-morpholineethanesulfonic acid and 0.0876g 0.05mol / L NaCl prepared by sterile deionized water into 30mL sterile deionized water, and use NaOH solution to adjust the pH value of the system to 5.1 to obtain 2-morpholineethanesulfonic acid buffer for standby use;

[0023] C2. Dissolve 3 mmol polyacrylic acid, 1 mmol EDC, 1 mmol N-hydroxysuccinimide and 5 mmol dopamine hydrochloride in 1 L 2-morpholineethanesulfonic acid buffer, stir well for 24 hours at room temperature under an inert gas atmosphere, and then freeze-dry in a freeze dryer to obtain an adhesion initiator.

[0024] (6) In a sterile environment, an adhesion initiator is covered on a pretreated glass sheet, an oxidant is added dropwise after two minutes, and then an acrylamide hydrogel is covered on the surface to which the oxidant is added dropwise, and pressure is applied at a strain of 10% for one hour to obtain a medical glass sheet. The specific steps are as follows:

[0025] Under a sterile environment, an adhesion initiator is added to deionized water, and stirred at room temperature until dissolved to obtain an adhesion initiator solution;

[0026] The adhesion initiator solution is covered on the pretreated glass sheet at a dosage of 17.6 μL / cm2. After two minutes, the oxidant is added dropwise, and then the acrylamide hydrogel is covered on the surface where the oxidant is added. The solution is spread evenly on the glass sheet with a thickness of 2-4 μm. The glass sheet is pressed at a strain of 10% for one hour to obtain a medical glass sheet.

[0027] In the above reaction process, the adhesion initiator uses a polyacrylic acid long-chain polymer as a skeleton, a grafted dopamine molecule on the skeleton as a functional pendant, and an oxidant as a trigger for intermolecular crosslinking. The benzene ring of the dopamine molecule carries two adjacent hydroxyl groups, which can form hydrogen bonds with the bidentate hydroxyl groups on catechol when encountering a glass solid composed of silicate. In the presence of an oxidant, some of the catechol groups on the polyacrylic acid long-chain polymer skeleton are oxidized to quinones, which can spontaneously couple with other catechols and form intermolecular crosslinks, increasing the connection between the hydrogel material and the glass interface. Due to the microporosity of the glass surface and the rich pores in the modified graphene material, the crosslinking of the polymer is further promoted and triggered to form a new network topologically entangled with the pre-existing network to develop topological adhesion, so that there is physical topological entanglement adhesion between the glass and the hydrogel.

[0028] Furthermore, the mass volume ratio of the silver ion antibacterial agent to the modified graphene is 100 mL: (50-150) mg.

[0029] Furthermore, the volume ratio of acrylamide solution to N,N′-methylenebisacrylamide solution is 5:(1-6), the volume ratio of crosslinking accelerator to precursor solution is 1:(3-7), and the mass ratio of N,N,N′,N′-tetramethylethylenediamine to acrylamide is 0.0028:1.

[0030] Further, the adhesion initiator is prepared by the following steps:

[0031] Furthermore, the mass ratio of polyacrylic acid, EDC, N-hydroxysuccinimide and dopamine hydrochloride is (700-750):0.192:0.115:0.948.

[0032] Furthermore, the oxidant is a 0.04 mol / L Na IO4 solution, and the usage amount is 4 μL / cm 2 .

[0033] Beneficial effects of the present invention:

[0034] (1) In the technical solution of the present invention, a composite antibacterial solution is prepared by using a silver ion antibacterial agent and modified graphene, and the silver ion antibacterial agent is prepared by using an environmentally friendly chelating agent (pentasodium diethylenetriamine pentaacetate) and a buffer (lauric acid), thereby increasing the stability and biocompatibility of silver ions in the system and reducing the impact of the silver ion antibacterial agent on the environment. Using modified graphene as an antibacterial component can, on the one hand, increase the antibacterial spectrum of the composite antibacterial solution, and on the other hand, like silver ions, it has good stability and good biocompatibility in the system, and will not be oxidized when in contact with an oxidant on a glass sheet, and still maintains good antibacterial activity. In addition, modified graphene has the characteristics of high temperature resistance, corrosion resistance, low surface energy and rich porous structure, which can increase the physical topological entanglement between the hydrogel system and the glass sheet and increase the adhesion effect of the material.

[0035] (2) In the technical solution of the present invention, the acrylamide hydrogel made of the composite antibacterial solution is connected to the glass sheet by using a cross-linking promoter. By combining the two methods of chemical bonding and topological entanglement, the adhesion effect of the hydrogel system on the glass sheet is increased, and even in a humid environment, a good adhesion effect is shown, achieving a long-term antibacterial effect. In addition, the hydrogel-coated glass sheet has the effect of absorbing moisture. When a separate glass sheet is needed, the gel is peeled off. The gel can keep the surface of the glass sheet dry and clean as a long-lasting antibacterial protective film, while preventing wear.

[0036] (3) In the technical solution of the present invention, since the silver ion antibacterial agent prepared by environmentally friendly chelating agents and buffers and the antibacterial agent prepared by modified graphene have good biocompatibility, the gel on the surface of the glass sheet is non-toxic to cells and has no impact on the environment. In addition, the sterile glass sheet with gel attached has a wider application in cell culture and medical equipment. For example, when using a blood glucose meter, the slide needs to avoid bacterial contamination, and blood can penetrate the gel into the instrument to achieve a long-term antibacterial effect. The gel-coated glass sheet has the effect of promoting cell proliferation. The aromatic amino acid residues of proteins and graphene have a strong π-π stacking interaction, which makes it easier to adsorb proteins driven by the graphene surface, and is a good cell culture container. DETAILED DESCRIPTION

[0037] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0038] The reagents used in the following examples and comparative examples are all of reagent grade, wherein the polyacrylic acid used is a 25 wt % aqueous solution with Mw=240,000.

[0039] Example 1

[0040] The modified graphene is prepared by the following steps:

[0041] A1. Disperse 100 mg of graphene oxide powder in 100 mL of sterile deionized ultrapure water, stir evenly, add polytetrafluoroethylene and perform ultrasonic treatment for 30 minutes to obtain a graphene oxide solution.

[0042] A2. Transfer the graphene oxide solution to a Teflon-lined autoclave, add 10 mL of hydrofluoric acid, stir and filter, then place the system in an oven and dry at 180 ° C for 12 hours, then naturally cool the mixture to room temperature, filter, discard the supernatant, wash the filter cake with sterile deionized water until the pH value of the washing solution is 7, and then dry again to obtain modified graphene.

[0043] Example 2

[0044] The composite antibacterial solution is prepared by the following steps:

[0045] 1.5 g of 30% diethylenetriamine pentaacetic acid pentasodium solution was added to 96.3 g of sterile deionized water, and after stirring evenly, 0.1 g of silver oxide powder was added, and after stirring at 30 rpm for 1 hour at room temperature, 0.1 g of lauric acid was added and continued to stir until the lauric acid was completely dissolved, and then filtered using a 0.22 μm filter to obtain a silver ion antibacterial agent;

[0046] 100 mL of the silver ion antibacterial agent was mixed with 50 mg of the modified graphene prepared in Example 1, and stirred at room temperature at a rate of 30 rpm until uniform, to obtain a composite antibacterial solution.

[0047] Example 3

[0048] The difference between this embodiment and embodiment 2 is that the amount of silver oxide powder used in this embodiment is 0.15 g, and the composite antibacterial solution is obtained by mixing 100 mL of silver ion antibacterial agent with 100 mg of modified graphene prepared in embodiment 1.

[0049] Example 4

[0050] The difference between this embodiment and embodiment 2 is that the amount of silver oxide powder used in this embodiment is 0.2 g, and the composite antibacterial solution is obtained by mixing 100 mL of silver ion antibacterial agent with 150 mg of modified graphene prepared in embodiment 1.

[0051] Example 5

[0052] Acrylamide hydrogel is prepared by the following steps:

[0053] B1. Under light-proof conditions, 13.52 g of acrylamide powder was added to 100 mL of the composite antibacterial solution prepared in Example 2, and stirred at room temperature until dissolved to obtain an acrylamide solution; 2 g of N, N′-methylenebisacrylamide was added to 100 mL of sterile deionized ultrapure water and stirred evenly to obtain an N, N′-methylenebisacrylamide solution; 10 mL of the N, N′-methylenebisacrylamide solution was mixed with 50 mL of the acrylamide solution to obtain a precursor solution;

[0054] B2, adding 20g of ammonium persulfate to 100mL of sterile deionized ultrapure water and stirring evenly to obtain an ammonium persulfate solution, then adding 0.38g of N,N,N',N'-tetramethylethylenediamine to the ammonium persulfate solution, stirring evenly to obtain a crosslinking accelerator;

[0055] B3. Evenly mix 10 mL of the cross-linking accelerator with 30 mL of the precursor solution to obtain a mixed solution for later use; add a layer of silica gel gasket to the reaction container, then transfer the mixed solution to the reaction container, and treat it in an oven at 50° C. for 5 hours to obtain acrylamide hydrogel.

[0056] Example 6

[0057] The difference between this embodiment and embodiment 5 is that the composite antibacterial solution used in this embodiment is prepared in embodiment 3, the precursor solution is obtained by mixing 30 mL of N, N′-methylenebisacrylamide solution with 50 mL of acrylamide solution, and the mixed solution is obtained by mixing 10 mL of a cross-linking accelerator with 50 mL of the precursor solution.

[0058] Example 7

[0059] The difference between this embodiment and embodiment 5 is that the composite antibacterial solution used in this embodiment is prepared in embodiment 4, the precursor solution is obtained by mixing 60 mL of N, N′-methylenebisacrylamide solution and 50 mL of acrylamide solution, and the mixed solution is obtained by mixing 10 mL of a cross-linking accelerator and 70 mL of the precursor solution.

[0060] Example 8

[0061] The adhesion initiator is prepared by the following steps:

[0062] C1, add 0.585g 0.1mol / L 2-morpholineethanesulfonic acid and 0.0876g 0.05mol / L NaCl prepared by sterile deionized water into 30mL sterile deionized water, and use NaOH solution to adjust the pH value of the system to 5.1 to obtain 2-morpholineethanesulfonic acid buffer for standby use;

[0063] C2. Dissolve 720 g of polyacrylic acid, 0.192 g of EDC, 0.115 g of N-hydroxysuccinimide and 0.948 g of dopamine hydrochloride in 1 L of 2-morpholineethanesulfonic acid buffer, stir well for 24 hours at room temperature under an inert gas atmosphere, and then freeze-dry in a freeze dryer to obtain an adhesion initiator.

[0064] Example 9

[0065] A method for cleaning and sterilizing medical glass sheets comprises the following steps:

[0066] S1, the total surface area is 25cm 2 The glass slide was washed 3 times with sterile deionized water, then soaked in a 75% ethanol solution, the surface of the glass slide was wiped with a cotton ball, then rinsed with a 75% ethanol solution, and finally dried in an ultraviolet sterilization dryer to obtain a pretreated glass slide;

[0067] S2. Under a sterile environment, add 4 g of the adhesion initiator prepared in Example 8 to 100 mL of deionized water, and stir at room temperature until dissolved to obtain an adhesion initiator solution;

[0068] S3. Cover the pretreated glass sheet with 400 μL of adhesion initiator solution, and after two minutes, drop 100 μL of 0.04 mol / L Na IO4 solution, and then cover the surface of the dropwise added Na IO4 solution with the acrylamide hydrogel prepared in Example 5, so that the solution is evenly spread on the glass sheet, the thickness is controlled to be 2 μm, and pressurize at a strain of 10% for one hour to obtain a medical glass sheet.

[0069] Example 10

[0070] The difference between this comparative example and Example 9 is that in step S2, the amount of the adhesive prepared in Example 8 used is 5 g, and the acrylamide hydrogel used in step S3 is prepared in Example 6, and the coverage height is 3 μm.

[0071] Embodiment 11

[0072] The difference between this comparative example and Example 9 is that in step S2, the amount of the adhesive prepared in Example 8 used is 6 g, and the acrylamide hydrogel used in step S3 is prepared in Example 7, and the coverage height is 4 μm.

[0073] Comparative Example 1

[0074] The difference between this comparative example and Example 10 is that in this example, a silver ion antibacterial agent is used instead of the composite antibacterial solution.

[0075] Comparative Example 2

[0076] In this comparative example, NaIO4 solution was not added dropwise.

[0077] Comparative Example 3

[0078] The comparative example is a medical glass sheet washed three times in sequence with sterile deionized water and 75% ethanol solution.

[0079] The medical glass sheets cleaned in Examples 9-11 and Comparative Examples 1-3 are now tested for their antibacterial effects. The killing effect of the fiber on Gram-positive bacteria, Gram-negative bacteria and fungi was measured. Bacillus, Escherichia coli and Candida albicans were taken as test strains. 5 mL of sterilized culture medium was poured into a 25 mL sterilized culture dish for solidification. In the solidified culture medium, a sterile steel drill was used to make holes in the agar medium with a pore size of 6 mm. The microbial suspension was evenly applied to the surface of the medical glass sheets cleaned in Examples 9-11 and Comparative Examples 1-3 with a sterile swab, and the plates were incubated at 37°C for 24 hours to achieve antibacterial activity, and incubated at 25°C for 48 hours to obtain antifungal activity. Five readings were obtained for each sample and the average was taken. The test results are shown in Table 1 below.

[0080] Table 1 Test of antibacterial effect of cleaned medical glass sheets in Examples 9-11 and Comparative Examples 1-3

[0081]

[0082] As shown in Table 1 above, the three embodiments all showed good antibacterial effects compared with the comparative examples, and the antibacterial effect on Candida albicans was the most significant, and the cleaned medical glass sheet in Example 10 had the best antibacterial effect. As shown in the results of Comparative Example 1, the combination with modified graphene can increase the antibacterial effect of the sample.

[0083] Now the effect of promoting cell proliferation of the cleaned medical glass sheets in Examples 9-11 and Comparative Examples 1-3 was tested. Each group of cleaned medical glass sheets was arranged under a culture dish, and L929 cells were incubated using a culture dish and DMEM culture medium. After 2 days, 1 mL of the cell suspension in the culture dish was transferred to a 24-well plate in sequence, and 4 wells were set for each group of samples. 100 μL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was added to each well. After 4 hours, the culture medium was removed, 750 μL of dimethyl sulfoxide was added, and the plate was placed on a shaker for 10 minutes, and then the absorbance was read at 490 nm using an ELISA reader. The test results are shown in Table 2.

[0084] Table 2 Test on the effect of cleaned medical glass sheets in Examples 9-11 and Comparative Examples 1-3 on promoting cell proliferation

[0085] project OD value (490nm) Proliferation rate (%) Example 9 0.37 132% Example 10 0.39 137% Embodiment 11 0.37 134% Comparative Example 1 0.33 90.3% Comparative Example 2 0.25 114% Comparative Example 3 0.20 88.9%

[0086] It can be seen from Table 2 that the cleaned medical glass sheets in the three embodiments have a promoting effect on the proliferation of L929 cells, and the glass sheets cleaned in Example 10 have the best promoting effect. It can be seen from the data in Comparative Example 1 that modified graphene is beneficial to promoting cell proliferation. Compared with the data in Comparative Example 3, it can be seen that the silver ion antibacterial agent has basically no effect on cell proliferation, has a promoting effect and good biocompatibility, showing the application potential of the cleaned glass sheets in the medical field.

[0087] In the description of the specification, the description with reference to the terms "one embodiment", "example", "specific example", etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representation of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described can be combined in any one or more embodiments or examples in a suitable manner.

[0088] The above contents are merely examples and explanations of the present invention. Those skilled in the art may make various modifications or additions to the specific embodiments described or replace them in a similar manner. As long as they do not deviate from the invention or exceed the scope defined by the claims, they shall all fall within the protection scope of the present invention.

Claims

1. A method for cleaning and sterilizing medical glass sheets, characterized in that: The following steps are involved: (1) After washing the glass slide with sterile deionized water for 3 times, soaking it in a 75% ethanol solution, wiping the surface of the glass slide with a cotton ball, rinsing it with a 75% ethanol solution, and finally drying it in an ultraviolet sterilization dryer to obtain a pretreated glass slide; (2) using polytetrafluoroethylene to disperse graphene oxide, and then using hydrofluoric acid to modify it to obtain modified graphene, which is stored for later use; (3) preparing a silver ion antibacterial agent, adding modified graphene to the silver ion antibacterial agent to obtain a composite antibacterial solution; (4) preparing acrylamide hydrogel using the composite antibacterial solution to obtain acrylamide hydrogel; (5) Under a sterile environment, a polyacrylic acid solution is prepared using sterile deionized water, and modified using dopamine hydrochloride to obtain an adhesion initiator; (6) Under a sterile environment, an adhesion initiator is coated on a pretreated glass sheet, an oxidant is added dropwise after two minutes, and then an acrylamide hydrogel is coated on the surface to which the oxidant is added, and pressure is applied at a strain of 10% for one hour to obtain a medical glass sheet.

2. A method for cleaning and sterilizing medical glass sheets according to claim 1, characterized in that: The modified graphene is prepared by the following steps: A1. Disperse graphene oxide powder in sterile deionized ultrapure water, stir evenly, add polytetrafluoroethylene and perform ultrasonic treatment for 30 minutes to obtain a graphene oxide solution; A2. Transfer the graphene oxide solution to a Teflon-lined autoclave, add hydrofluoric acid, stir, filter, and then place the system in an oven and dry at 180°C for 12 hours. Then, cool the mixture naturally to room temperature, filter, discard the supernatant, wash the filter cake with sterile deionized water until the pH value of the washing solution is 7, and then dry again to obtain modified graphene.

3. A method for cleaning and sterilizing medical glass sheets according to claim 1, characterized in that: The composite antibacterial solution is prepared by the following steps: Add a 30% concentration of diethylenetriamine pentaacetic acid pentasodium solution into sterile deionized water, stir evenly, then add silver oxide powder, stir at 30 rpm for 1 hour at room temperature, add lauric acid and continue stirring until the lauric acid is completely dissolved, and filter with a filter to obtain a silver ion antibacterial agent; The silver ion antibacterial agent and the modified graphene were mixed, and stirred at a rate of 30 rpm at room temperature until they were uniform, thereby obtaining a composite antibacterial solution.

4. A method for cleaning and sterilizing medical glass sheets according to claim 3, characterized in that: The mass volume ratio of the silver ion antibacterial agent to the modified graphene is 100mL:(50-150)mg.

5. A method for cleaning and sterilizing medical glass sheets according to claim 1, characterized in that: Acrylamide hydrogel is prepared by the following steps: B1. Add acrylamide powder to the composite antibacterial solution under light-proof conditions, and stir at room temperature until dissolved to obtain an acrylamide solution; add N,N′-methylenebisacrylamide to sterile deionized ultrapure water and stir evenly to obtain an N,N′-methylenebisacrylamide solution; mix the N,N′-methylenebisacrylamide solution with the acrylamide solution to obtain a precursor solution; B2, adding ammonium persulfate to sterile deionized ultrapure water and stirring evenly to obtain an ammonium persulfate solution, then adding N,N,N',N'-tetramethylethylenediamine to the ammonium persulfate solution, stirring evenly to obtain a crosslinking accelerator; B3. After the cross-linking accelerator and the precursor solution are evenly mixed, a mixed solution is obtained and set aside; a layer of silicone gasket is added to the reaction container, and then the mixed solution is transferred to the reaction container, and treated in an oven at 50° C. for 5 hours to obtain acrylamide hydrogel.

6. A method for cleaning and sterilizing medical glass sheets according to claim 5, characterized in that: The volume ratio of acrylamide solution to N,N′-methylenebisacrylamide solution is 5:(1-6), the volume ratio of crosslinking accelerator to precursor solution is 1:(3-7), and the mass ratio of N,N,N′,N′-tetramethylethylenediamine to acrylamide is 0.0028:

1.

7. A method for cleaning and sterilizing medical glass sheets according to claim 1, characterized in that: The adhesion initiator is prepared by the following steps: C1, adding 2-morpholineethanesulfonic acid and NaCl solution prepared by sterile deionized water into sterile deionized water, and adjusting the pH value of the system to 5.1 with NaOH solution to obtain 2-morpholineethanesulfonic acid buffer for standby use; C2. Dissolve polyacrylic acid, EDC, N-hydroxysuccinimide and dopamine hydrochloride in 2-morpholineethanesulfonic acid buffer, fully stir at room temperature and in an inert gas atmosphere for 24 hours, and then freeze-dry in a freeze dryer to obtain an adhesion initiator.

8. A method for cleaning and sterilizing medical glass sheets according to claim 7, characterized in that: The mass ratio of polyacrylic acid, EDC, N-hydroxysuccinimide and dopamine hydrochloride is (700-750):0.192:0.115:0.

948.

9. A method for cleaning and sterilizing medical glass sheets according to claim 1, characterized in that: Medical glass sheets are obtained by the following steps: Under a sterile environment, an adhesion initiator is added to deionized water, and stirred at room temperature until dissolved to obtain an adhesion initiator solution; The adhesion initiator solution is covered on the pretreated glass sheet, and the oxidant is added after two minutes. Then, the acrylamide hydrogel is covered on the surface where the oxidant is added, so that the solution is evenly spread on the glass sheet, and the thickness is controlled to be 2-4μm. After being pressed at a strain of 10% for one hour, a medical glass sheet is obtained.

10. A method for cleaning and sterilizing medical glass sheets according to claim 9, characterized in that: The oxidant is 0.04 mol / L Na IO4 solution.